Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes

Diabetes

Volumn 47, Issue 1, 1998, Pages 39-44

  Ploix, Corinne ^a   Bergerot, Isabelle ^a   Fabien, Nicole ^a   Perche, Stéphanie ^a   Moulin, Valérie ^a   Thivolet, Charles ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; RECOMBINANT HUMAN INSULIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL CLONE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; IMMUNOHISTOCHEMISTRY; INSULITIS; LYMPH NODE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE ACTIVATION;

EID: 0031985550     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.39     Document Type: Article

References (30)

1. Castano L, Eisenbarth GS: Type-1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu Rev Immunol 8:647-679, 1990
2. Makino S, Kunimoto K, Mureoka Y, Mizushima Y, Katagiri X, Tochino Y: Breeding of a non-obese diabetic strain of mice. Exp Anim 29:1-13, 1980
3. Wells H: Studies on the chemistry of anaphylaxis, III. Experiments with isolated proteins, especially those of hen's egg. J Infect Dis 9:147-151, 1911
4. Friedman A, Weiner HL: Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91:6688-6692, 1994
5. Michel C, Boitard C, Bach JF: Insulin auto-antibodies in nonobese diabetic (NOD) mice. Clin Exp Immunol 75:457-460, 1989
6. Wegmann DR, Norbury-Glaser M, Daniel D: Insulin-specific T-cells are a predominant component of islet infiltrates in the pre-diabetic NOD mice. Eur J Immunol 24:1863-1857, 1994
7. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Pacquette TL: Insulin antibodies in insulin dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
8. Keller RJ: Cellular immunity to human insulin in individuals at high risk for the development of type 1 diabetes mellitus. J Autoimmun 31:321-327, 1990
9. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in non-obese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256, 1991
10. Bergerot I, Fabien N, Maguer V, Thivolet C: Oral administration of human insulin to NOD mice generates CD4+ T-cells that suppress adoptive transfer of diabetes. J Autoimmun 7:655-663, 1994
11. Yasunami R, Bach JF: Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 18:481-484, 1988
12. Fabien N, Bergerot I, Maguer-Satta V, Orgiazzi J, Thivolet C: Pancreatic lymph nodes are early targets of T-cells during adoptive cell transfer of diabetes in NOD mice. J Autoimmun 8:323-334, 1995
13. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299, 1979
14. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffamn RL: Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357, 1986
15. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF: IFN gamma gene expression in pancreatic islet infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 154:4874-4882, 1995
16. Rabinovitch A, Suarez-Pinzon WL, El-Sheikh A, Sorensen O, Power RF: Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with β-cell destructive insulitis and IDDM. Diabetes 45:749-754, 1996
17. Shehadeh NN, LaRosa F, Lafferty K: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300, 1993
18. Muir A, Peck A, Clare-Salzer M, Song YH, Cornelius J, Luchetta R, Krischer J, MacLaren NK: Insulin immunization of NOD mice induced a protective insulitis characterized by diminished intra-islet interferon gamma transcription. J Clin Invest 95:628-634, 1995
19. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovitch TL: Interleukin 4 reverses T-cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 178:87-99, 1993
20. Mueller R, Krahl T, Sarvetnick N: Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 184:1093-1099, 1996
21. Sad S, Mosmann TR: Interleukin (IL)-4 in the absence of antigen stimulation induces an anergy like state in differentiated CD8+ TC1 cells: loss of IL2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J Exp Med 182:1505-1515, 1995
22. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte V: Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice: analysis of cytokine mRNA expression in the graft. Transplantation 60:368-374, 1995
23. Lee MS, Mueller R, Wicker LS, Peterson LB, Sarvetnick N: IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J Exp Med 183:2663-2668, 1996
24. Hancock WW, Polanski M, Zhang J, Blogg N, Weiner HL: Suppression of insulitis in non obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin 4 and 10, transforming growth factor β and prostaglandin E. Am J Pathol 147:1193-1199, 1995
25. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA: Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens: Ann Rev Immunol 12:809-837, 1994
26. Von Herrath MG, Dyrberg T, Oldstone MBA: Oral insulin suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324-1331, 1996
27. MacKay CR, Marston W, Dudler W: Naive and memory T-cells show distinct pathways of lymphocyte recirculation. J Exp Med 171:801-817, 1990
28. Fabien N, Bergerot I, Orgiazzi J, Thivolet C: Lymphocyte function associated antigen-1, integrin α4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes 45:1181-1186, 1996
29. Harrison LC, Dempsey-Collier M, Kramer DR, Takahashi K: Aerosol insulin induces regulatory λδ T-cells that prevent murine insulin-dependent diabetes. J Exp Med 184:2167-2174, 1996
30. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Mayer A, Czerkinsky C, Holmgren J, Thivolet C: A cholera toxoid insulin conjugate as oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci USA 94:4610-4614, 1997